Global private equity (PE) fund Advent International and Chinese strategic investor Fosun International Ltd are in separate talks to acquire a controlling equity stake in Indore-based Symbiotec Pharmalab Pvt. Ltd from existing investor Actis Capital, according to two people privy to the development.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
